As drug discovery demands greater speed and accuracy, advances in automation are transforming high-throughput screening. Rob ...
In this interview, James Atwood, CEO of Opentrons, discusses the tasks most ripe for automation today, what “autonomous ...
interview Amazon has seen a 40 percent efficiency gain by using AI tools to pentest its products before and after launch, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results